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Congenital Anomalies of the Kidney and Urinary Tract
(CAKUT) are a major cause of morbidity in children. We
measured the risk of progression to end-stage renal disease
in 312 patients with CAKUT preselected for the presence of
anomalies in kidney number or size. A model of dialysis-free
survival from birth was established as a function of the renal
CAKUT categories of solitary kidney; unilateral and bilateral
hypodysplasia; renal hypodysplasia associated with posterior
urethral valves; and multicystic and horseshoe kidney. Cox
regression analysis took into account the concomitant
presence of vesicoureteral reflux, year of diagnosis, and time-
varying values of serum creatinine, proteinuria, and
hypertension. By 30 years of age, 58 patients had started
dialysis, giving a yearly incidence of 0.023 over a combined
2474 patient risk years. The risk for dialysis was significantly
higher for patients with a solitary kidney or with renal
hypodysplasia associated with posterior urethral valves
(hazard ratios of 2.43 and 5.1, respectively) compared to
patients with unilateral or bilateral renal hypodysplasia, or
multicystic or horseshoe kidney, and was independent of
other prognostic factors. Our study shows that sub-clinical
defects of the solitary kidney may be responsible for a poorer
prognosis compared to more benign forms of CAKUT.
Prospective studies are needed to validate these results.
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Congenital anomalies of the kidney and urinary tract are a
major cause of morbidity and collectively represent a
significant cause of Chronic Kidney Disease in children and
young adults.1–4 Moreover, reduced nephron mass can
predispose to adult-onset diseases such as hypertension and
chronic renal failure.5 Data from birth defect registries6–9
indicate a prevalence of these congenital anomalies varying
from 3 to 6 per 1000 births, with relevant impact on life
expectancy (http://www.marchofdimes.com). However, to the
best of our knowledge, studies on renal survival of congenital
abnormalities of the kidney and urinary tract have not been
conducted. One reason can be traced to the intrinsic difficulty
in carrying out a cohort study for conditions that are present
at birth and in which the follow-up may need to be extended
for decades. Another problem arises from the existence of
different phenotypes, which can present incomplete pene-
trance, variable aggregation and clinical presentation, thus
making uniform and extended data collections difficult and
introducing selection bias. A broad but clinically useful
diagnostic scheme consists in the classification of malforma-
tions depending on whether the kidney, the collecting system,
or both are affected. The uncertainty in the clinical
classification resulted in the aggregation of different entities
under the single label acronym Congenital Anomalies of the
Kidney and Urinary Tract (CAKUT): Congenital Anomalies of
the Kidney and Urinary Tract.10 There is not only clinical but
also genetic support to the use of CAKUT, because it is well
known that mutations in a single gene can have pleiotropic
effects on the development of the urogenital tract. For
example, mutations in the PAX2 gene are associated with
the renal coloboma syndrome, a rare autosomal-dominant
disorder in which different individuals in the same family can
present various anomalies, including renal agenesis/hypodys-
plasia, vesicoureteral reflux (VUR) and/or secondary obstruc-
tion.11 Another example is the gene for autosomal-dominant
renal hypodysplasia (OMIM %610805) localized on chromo-
some 1p32–33, in which family members of index cases with
hypodysplastic kidneys showed ureteric anomalies.12
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Although the term CAKUT can be useful for a general
classification, it may not be useful from an epidemiological
perspective as different clinical, anatomical, and genetic
entities may have different prognoses. In this paper, we report
longitudinal data on a cohort of 312 children referred for
different renal and urinary tract anomalies who were
followed until the age of 30 years. The basic criteria for
enrollment included the presence of CAKUT characterized by
a defect of the number or size of at least one kidney,
excluding cases with isolated ureteric anomalies such as
vesicoureteral reflux and duplicated collecting systems.
RESULTS
Clinical characteristics of the study cohort are described in
Table 1. Subjects were subdivided into 6 CAKUT categories as
described in the methods section and were enrolled over 20
years (number of patients enrolled per year: 9.7±2.2 before
1990 and 21.5±8.1 after 1990). The main criteria for
enrollment were the presence of a defect in size or number
of at least one kidney and the exclusion of all syndromic
associations and familial forms of disease. Isolated ureteric
conditions such as vesicoureteral reflux and duplicated
collecting systems without congenital anomalies of the
kidney were excluded from this study. For most of the
categories there was a clear prevalence of male patients by a
factor of about three, with the only exceptions of multicystic
kidney (M/F¼ 0.9) and of posterior urethral valves, observed
only in male patients, as expected. Neonatal diagnosis was
made in 56% of the patients with ample variability among
CAKUT categories. As expected the majority of patients with
multicystic dysplastic kidney and bilateral hypodysplasia were
diagnosed at or before birth whereas only about 50% of
patients belonging to the other categories were diagnosed at
this time. Postnatal diagnosis was made in these patients
because of other clinical signs, such as proteinuria and/or
hypertension or, in a large fraction of individuals, by imaging
studies conducted for other reasons, highlighting the fact that
the unilateral defect can be present in asymptomatic
individuals and therefore be underdiagnosed.
All patients with posterior urethral valves had at least one
surgical treatment and almost 50% had neonatal urinary
tract diversion. Fifty-three percent of the children with
solitary kidney and VUR had a surgical treatment consisting
of reimplantation (22%) or surgical cystoscopic correction
(29%); all had been treated with prophylaxis for urinary tract
infection for at least 1 year. Only three patients with
multicystic kidneys had nephrectomy.
By 30 years of age (median follow-up 6 years, range 2–30),
58 patients started dialysis. During the study there were 2474
patient-years at risk, with an incidence rate of 0.023 per year
(95% confidence interval from 0.018 to 0.030 per year).
This yearly incidence rate remained approximately constant
over time. Censored individuals with follow-up times
shorter than the median were similar to those observed for
longer time. The unadjusted risk for dialysis commencement
associated with group E or F (incidence rate 0.005, 95%
0.001 to 0.022) was similar to B diagnosis (0.007, 95% CI
0.002 to 0.020). This crude risk estimate was greater in
category A (0.023, 95% CI 0.015 to 0.035), C (0.029, 95% CI
0.012 to 0.071) and D (0.048, 95% CI 0.032 to 0.070).
Controlling for time-varying values of serum creatinine,
proteinuria, referral period, and concomitant presence of
VUR, a significantly different clinical course was observed
by CAKUT category (Figure 1). Dialysis survival
probabilities were greater for categories F (no events) and E
(two events), and for category B (four events) as compared
with categories C (five events), A (21 events), and D
(26 events). It is interesting that except for posterior
urethral valves and bilateral hypodysplasia, renal deteriora-
tion may not be detectable until late adolescence. This
observation highlights the importance of a smooth transition
of care for patients from pediatric to adult nephrology
services. Notably patients with bilateral hypodysplasia,
(with high creatinine and proteinuria at diagnosis) did not
progress to ESRD faster than patients with solitary kidney.
One possible explanation is that patients with unilateral
defects are usually considered to have a good prognosis and
therefore they may not have been stringently monitored. If
our results are true, patients with a solitary kidney should be
considered as having a progressive disease. These patients
would in fact require the same attention as those with
bilateral hypodysplasia and posterior urethral valves to
control all other possible co-morbidities, such as hyperten-
sion and proteinuria.
Table 1 | Patient characteristics by CAKUT category
Gender
Neonatal
diagnosis
Neonatal
creatinine
Age at
diagnosis
post-natal
Creatinine
at diagnosis
Proteinuria
41 g/day at
diagnosis
Hypertension
at diagnosis
ACEi within
1 year of
diagnosis
Dialysis at
follow-up
Category (n) Female Male
Count
(%)
Mean mg
per 100ml (s.d.)
Mean years
(s.d.)
Mean mg
per 100ml (s.d.) Count (%) Count (%) Count(%)
Count
(years±s.d.)
SK (71) 19 52 29 (41) 0.68 (0.95) 15 (15.4) 0.68 (0.70) 5 (7) 2 (2.8) 0 (0) 21 (21±13.6)
URHD (93) 27 66 45 (48) 0.48 (0.61) 2.3 (3.5) 0.43 (0.25) 6 (6.4) 0 (0) 24 (26) 4 (15±2)
BRHD (19) 4 15 14 (74) 1.46 (1.29) 1.09 (0.59) 0.76 (0.27) 9 (47) 2 (10.5) 4 (21) 5 (8.4±2.8)
PUV (68) 0 68 39 (57) 1.51 (2.13) 3.51 (2.9) 0.70 (0.91) 18 (26.4) 1 (1.4) 26 (38) 26 (12±6 )
MCDK (40) 21 19 36 (90) 0.46 (0.34) 4.76 (8.6) 0.42 (0.10) 0 (0) 1 (2.5) 0 (0) 2 (20±11)
HSK (21) 8 13 11 (52) 0.28 (0.09) 5.4 (7.9) 0.31 (0.10) 3 (14.2) 0 (0) 5 (24) 0
ACEi: angiotensin-converting enzyme inhibitor; BRHD: bilateral renal hypodysplasia; HSK: horseshoe kidney; MCDK: multicystic dysplastic kidney; PUV: posterior urethral
valves; SK: solitary kidney; URHD: unilateral renal hypodysplasia.
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Male gender predicted shorter renal survival in crude
analysis but not in adjusted models. This confounding effect
is probably due to the fact that urethral valves are restricted
to male patients. As expected the hazard for event occurrence
increased with higher values of serum creatinine (HR 2.27;
95% CI 1.88, 2.72; per mg per 100ml) and was greater in the
presence of proteinuria (6.42; 95% CI 3.94, 10.45; values 4
vs p1 g/day). No other specific factor (age at diagnosis,
surgical treatment, selected drugs) was found to influence the
outcome.
Figure 2 shows the final Cox model stratified by referral
period (before vs 1990 and thereafter). As compared to
subjects with multicystic kidney, horseshoe kidney or
unilateral hypodysplasia, those with bilateral hypodysplasia
did not show a significantly greater risk for dialysis initiation
by 30 years of age. Conversely, both solitary kidney (Hazard
Ratio 2.43, 95% CI 1.09 to 5.4) and posterior urethral valves
diagnoses (HR 5.1, 95% CI 1.9, 13.7) predicted worse
outcomes independent of the other covariates in the model
(vesicoureteral reflux and change in the levels of serum
creatinine and proteinuria). Table 2 shows the hazard ratios
for dialysis initiation by the age of 30 years by combination of
CAKUT categories and the presence and absence of VUR.
DISCUSSION
There are few studies on long-term outcome of patients with
CAKUT because of the lack of a homogeneous classification
and because of difficulties in separating the different
subphenotypes. Moreover, results derived from the analysis
of clinical parameters in different databases cannot readily be
compared because of possible differences in enrollment
criteria and heterogeneity of the applied technical ap-
proaches. For these reasons we still lack data on the long-
term outcome of children presenting an anomaly of the
number (single kidney) or size (hypodysplasia) of the kidneys
with the exception of renal hypodysplasia associated with
posterior urethral valves.13–16 This study included a homo-
geneous population of children and young adults enrolled in
a single national referral center, where the same physicians
utilized the same standardized diagnostic and classification
approaches. The main enrollment criterion for this study was
the diagnosis of a primary congenital anomaly of renal
morphology that was associated with a defect in the number
or size of at least one kidney. This choice was dictated by the
necessity to exclude patients with isolated VUR or other
primary urinary tract anomalies, such as duplicated collect-
ing systems, which may represent different clinical entities
with relatively good prognosis. Moreover, the goal of this
study is to assess the prognosis of patients with a primary
defect in kidney parenchyma development associated or not
to other urinary tract anomalies. The inclusion of patients
carrying a defect of renal size may lead to misinterpretations
of hypoplasia and dysplasia. Only kidney biopsy, considered
unethical because of the relevant risk of bleeding in small
kidneys or kidney function impairment in most serious cases,
can help to make a distinction. Therefore, patients with renal
hypoplasia and dysplasia were considered in the same
category, under the hypodysplasia phenotype. This could
constitute a limitation, as the two conditions may carry a
different hazard of renal function decline and the estimated
hazard associated with hypodysplasia may not reflect the true
hazard of either of them. Scarring processes due to VUR and
infections may contribute to kidney shrinking. Thus, VUR
associated with primary renal hypodysplasia should be
distinguished from secondary parenchymal scars.17–19
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Figure 1 | Survival probabilities by CAKUT category, adjusted
for the concomitant presence of vesicoureteral reflux, time-
varying values of serum creatinine (mg per 100ml) and
proteinuria ( X1g/day vs less), and referral period (before
1990 vs 1990 and thereafter).
Variables in the equation (HR, 95% Cl)
Hazard ratios (Log scale)
0.6 1.00 1.5 2.5 3.3 5.2 7.2 10.0
Solitary kidney*: 2.43 (1.09, 5.4)
Bilateral hypodysplasia*: 1.79 (0.49, 6.51)
Posterior urethral valves*: 5.1 (1.89, 13.8)
Vesicoureteral reflux (Y vs N): 3.09 (1.28, 7.0)
Creatinine (Mg per 100 ml): 2.21 (1.83, 2.66)
Proteinuria (Y vs N): 2.88 (1.32, 6.28)
Figure 2 | Forest plot of the hazard ratios associated with the
variables in the final Cox’s model of renal survival (model
stratified by referral period, before 1990 vs 1990 and
thereafter). The reference level (*) for the effect estimates
associated with the CAKUT categories (solitary kidney, bilateral
hypodysplasia and posterior urethral valves) includes multicystic
kidney, horseshoe kidney, and unilateral hypodysplasia.
Table 2 | Hazard ratios (HRs) and 95% confidence intervals
(95% CI) by combination of CAKUT category and concomitant
vesicoureteral reflux (model adjusted for time-varying levels
of serum creatinine and proteinuria, and stratified by referral
period; multiplicative model)
Vesicoureteral reflux
VUR absent VUR present
CAKUT categorya HR 95% CI HR 95% CI
Solitary kidney 2.42 1.08, 5.40 7.50 2.72, 20.68
Bilateral hypodysplasia 1.78 0.49, 6.52 5.52 1.04, 29.37
Posterior urethral valves 5.10 1.88, 13.1 15.8 2.8, 88.8
aReference category: multicystic kidney, horseshoe kidney, unilateral hypodysplasia.
VUR: vesicoureteral reflux.
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Dimercaptosuccinic acid (DMSA) scan is the technique of
choice to distinguish between the two categories and has been
used in our study to differentiate primary hypodysplasia and
reduced kidney size secondary to reflux nephropathy. DMSA
scan was generally normal at enrollment in patients with a
solitary kidney whereas in the VUR it showed the presence of
scars in some individuals. In these patients the presence of
both solitary kidney and VUR resulted in an additive effect
(but no interaction, see below) for progression to end-stage
renal failure (Table 2).
This study reports clinical outcome data on a large cohort
of patients with different anatomic categories belonging to
the CAKUT complex. Patients were followed for a variable
period of time until 30 years of age. These data are of unique
value for addressing the long-term outcome. However, the
observational design of the study raises the concern that
some form of bias accounts for the findings. In fact, some
factors potentially impacting outcome such as the presence of
proteinuria, hypertension and the disparity of pharmacolo-
gical treatment based on angiotensin-converting enzyme
inhibitors (ACEi) in recent years were unequally distributed
by CAKUT categories. This may mask confounding by other
unmeasured factors or have introduced confounding per se. It
is noteworthy that proteinuria greater than 1 g per day was
more frequent in patients with bilateral than in those with
unilateral hypodysplasia in spite of similar progression.
Moreover, ACEi have been utilized in a quite different
manner in the two categories with the worst outcome, such
as in patients with solitary kidney and in patients with
urethral valves. However, assuming that ACEi therapy is
nephro-protective in CAKUT patients (which might not be
true in children with hypodysplastic kidney20), the effect of
confounding in this case would push the results of the
present analysis toward the null hypothesis. Most impor-
tantly, excluding and including all these factors as covariates
in our analytical model did not change the results. Another
potential limitation may be the over-sampling of patients
with worse prognosis as compared to those usually referred
to peripheral centers, resulting in an ascertainment bias,
which would not make our results promptly applicable to the
general population. Finally, prognosis may have changed over
time due to the introduction of routine prenatal ultrasono-
graphy and improvement of the diagnostic and therapeutic
strategies. This additional source of bias was accounted for by
stratifying the survival model by study period.
Our findings indicate an overall poor renal survival for
CAKUT patients, only partially expected on the basis of the
available literature. As expected, high serum creatinine,
presence of proteinuria and VUR were associated with a
higher risk of progression to renal disease in all CAKUT
categories. Survival data by CAKUT subgroups showed a
significantly poorer outcome for patients carrying bilateral
renal hypodysplasia, solitary kidney, and posterior urethral
valves, compared with the other categories. The high risk of
renal replacement therapy in patients with posterior valves of
urethra is not new and is in agreement with data from the
literature.13–16 The clinical outcome of patients with a single
kidney was instead unexpected and raises the possibility of
subclinical renal defects in the solitary kidney. These
differences in the overall risk of developing ESRD were
independent of the concomitant presence of VUR and other
risk factors such as kidney function parameters and
proteinuria. Subjects who left the study earlier were similar
to those who remained under observation for longer times,
both within and across disease categories. Although this does
not exclude the possibility that the independent censoring
assumptions be violated, it is unlikely that those with only
certain disease categories and worse outcomes systematically
failed to be referred back to the center.
According to the chosen model, the effect of CAKUT
categories was not modified by the presence of VUR (no
evidence of interaction). However, it is important to note
that in multiplicative models (for example, the Cox’s model)
the effects are measured as ratios and the joint effect of two
or more factors is the product (rather than the sum) of their
effects (Table 2). Interaction parameters are ratios chosen to
measure departures from a multiplicative model. Statistical
assessment of this departure tests whether there is a departure
from multiplicativity rather than the existence of a biological
phenomenon.21 Nevertheless, the relatively small sample size
can make interaction estimates across six categories inaccurate.
Outcome data from patients with congenital solitary
kidney are limited.22–25 The literature abounds instead of
follow-up data of surgical solitary kidneys generally asso-
ciated with favorable outcome.26 Data from the transplanta-
tion program in Sweden showed that the risk of ESRD at 12
years was less than 0.6% in kidney donors.26 Long-term
survivors from a Wilms’ tumor diagnosed during childhood
experienced a risk of ESRD of 1.19% over a period of time
comparable with the one of this study (Oeffinger KC,
personal observation).
In conclusion, this study represents a complete and
adequately sized report on clinical outcome of patients with
CAKUT phenotypes. The national referral, single center
design allowed the standardization of enrollment criteria,
diagnostic approaches, and therapeutic strategies. The
detailed follow-up and statistical model used accounted for
many measured potential confounders and covariates, thus
making the overall results reliable and clinically useful for
assessing the risk of progression to ESRD of different CAKUT
categories. It is noteworthy that the unexpected high risk in
patients with solitary kidney highlights potential subclinical
defects of the solitary kidney, which may account for a poorer
prognosis as compared with other forms of the CAKUT
complex. Randomized prospective studies are needed to
investigate the applicability of these results to the general
population of patients with CAKUT.
MATERIALS AND METHODS
Patients
To be eligible for this study, patients had to have been followed at
the Nephrology Department of the G Gaslini Children Hospital as in
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and/or outpatients between 1980 and 2000 and had to have been
diagnosed with any urinary tract malformation belonging to the
CAKUT diagnostic group including a defect of the renal
parenchyma documented by renal ultrasonography and DMSA
scan. Isolated ureteric anomalies such as non-syndromic VUR and
duplicated collecting systems represent different entities with higher
prevalence in the general population and favorable outcome and
were, therefore, excluded. Moreover, these cases were excluded
because they were not representative of conditions with defective
renal parenchyma. Familial cases and patients presenting one or
more extra-renal features were excluded.
Therefore, the CAKUT categories analyzed in this study include
any primary anomaly of the kidney number, size and/or morphol-
ogy associated with additional malformations of the urinary tract.27
Six major phenotypes were recognized for our study: (A) solitary
kidney with or without defects of the urinary tract; (B) unilateral
renal hypodysplasia with/without urinary tract defects; (C) bilateral
renal hypodysplasia with/without urinary tract defects; (D) renal
hypodysplasia associated with stenosis of urethral valves; (E)
multicystic kidney; and (F) horseshoe kidney.
For this study, either renal hypoplasia or dysplasia was defined as
hypodysplasia because of the impossibility to make a reliable
distinction between these entities. The category solitary kidney
comprises kidney agenesis and the ‘empty renal fossa’ on imaging
studies (static renal scintigraphy and ultrasonography) that can
result from the involution of a multicystic dysplastic kidney. Because
only prenatal ultrasonography, not always available, can distinguish
between these two conditions, the general term of solitary kidney
has been adopted. Hypodysplasia was considered in the presence of a
reduction of renal size by two s.d. from the mean size for the age,
with clear exclusion of renal scarring by DMSA scan and in the
presence of compensatory hypertrophy of the contralateral kidney.28
The categories from A to D present renal hypodysplasia, justifying the
inclusion in this study. Multicystic kidney fits into the CAKUT
category because it combines lack of normal renal tissue such as
glomeruli and collecting ducts with the presence of primitive tubules
surrounding the stroma.29,30 The following criteria identified multi-
cystic kidneys: presence of a unilateral multiloculated abdominal mass
with thin-walled cysts and with lack of tissue inside; presence of atresic
ureter; the previous two conditions with associated hydronephrosis
(hydronephrotic variant); no functional parenchyma at scintigraphy;
no detectable renal artery by Doppler ultrasonography.
For each eligible patient data were collected on demographics, type
of malformation, date of diagnosis and date of onset of ESRD that
required replacement therapy, such as hemodialysis and/or peritoneal
dialysis. Clinical criteria for starting replacement therapy included the
presence of metabolic acidosis, hyperkalemia, increase of body weight
over 10% in 1 week, oliguria, severe and intractable hypertension,
severe nausea and failure to thrive. No patients were subjected to pre-
emptive transplantation. Hypertensive state, serum creatinine and
proteinuria within the first year of age and repeated during follow-up
were collected, together with specific surgical and medical treatments.
Imaging studies
Static renal scintigraphy was recorded 3–4 h after injection of a
weight-scaled dose of technetium-99m DMSA to obtain views in the
posterior and both posterior oblique projections for 300 kilocounts or
more. Focal or diffuse areas of decreased uptake in the first scan,
without evidence of cortical loss, indicated acute pyelonephritis.
Renal scarring was defined as decreased uptake with distortion of the
contours or as cortical thinning with loss of parenchymal volume.
Two nuclear physicians, blinded to the test results, interpreted the
scans independently and resolved discrepancies by discussion.
Statistical analyses
Univariate analyses. Data are expressed as mean±s.d.,
median and inter-quartile range, or frequencies, as appropriate.
Survival functions. Cox’s regression was used to model renal
survival as a function of the CAKUT categories. As the conditions of
interest are by definition congenital, survival was measured from
birth and follow-up carried out until December 2006, the date of the
last visit, the date of dialysis initiation for ESRD, or the thirtieth
birthday, whichever occurred first. Differences in penetrance or
severity of the disease at presentation were taken into account
including both time-invariant clinical characteristics (gender, serum
creatinine, hypertensive state and proteinuria within the first year of
age), concomitant vesicoureteral reflux, and time-varying values of
repeated lab measures (serum creatinine and proteinuria), diagnosis
of hypertension during follow-up and antihypertensive therapies. All
repeated measures for each patient were averaged to obtain one
5-year mean value and mitigate the effect of short-term variations.
Hence, up to six varying values of serum creatinine (mg per 100ml),
proteinuria (p1 g/day or greater) and hypertension diagnosis
(present vs absent) were available for each individual. Changes in
the practice patterns and center experience were accounted for by
considering the period of children referral in the analyses (that is,
after 1990 vs before 1990). Centers of origin (regions or countries)
were also considered to take into account possible differences in the
follow-up care, genetic background or other potential unmeasured
confounders.
Model building. The largest possible meaningful model
considered included the CAKUT categories, time-invariant and
time-varying covariates, and interpretable interaction terms, con-
sidering the overall model fit and hazard proportionality. A manual
hierarchical elimination approach was followed, monitoring varia-
tions of the exposure regression coefficient to identify variables that
were eligible to be dropped as non-confounders and non-modifiers.
The contribution of the covariates to explain the dependent variable
was assessed by means of a two-tailed Wald test, with P-values
o0.05 considered as significant. Model specification, proportionality
assumption and overall fit were checked by re-estimation, formal and
graphical tests based on residuals, and testing the interaction with time
of the variables in the model. Sensitivity analyses were conducted to
check the robustness of the final model, considering influential
observations and outliers, and censored follow-up times shorter than
the median value. Analyses were performed using the STATA 9.2 SE
software (Stata Corp, College Station, TX, USA).
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